Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Post-menarchal women (≥18 years) at the time of signing the informed consent.
Women with histologically confirmed NAEH independent of their parity or menopausal status. Endometrial samples will be obtained either at screening or no more than 42 days prior to the signing of the informed consent form.
You may not be if
Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results.
Congenital or acquired uterine or cervical anomaly including fibroids, or cervical stenosis that in the opinion of the investigator, would interfere with insertion and/or retention of the intrauterine system (i.e., if they distort the uterine cavity).
Use of any long-acting injectable sex-hormone preparations within 6 months prior to the start of study intervention, and /or short acting hormonal medication within 6 weeks prior to the start of study intervention.
Pregnancy
Participants with either known family or personal history of genetic predisposition to uterine, ovarian or colorectal cancers (e.g. Lynch syndrome).
Clareo Health | Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
